biomarkers Clinical Trials and Research
Also known as: biological markers, disease markers, molecular markers, predictive markers, prognostic markers, diagnostic markers, surrogate endpoints
Biomarkers are measurable indicators of a biological state, such as specific molecules or genetic changes, that can signal the presence or progression of a disease or how the body responds to a treatment. Clinical trial research actively focuses on discovering new biomarkers and using them to improve disease diagnosis, predict outcomes, and personalize therapies across many conditions. Find a Trial helps patients search active studies.
Common questions about biomarkers clinical trials
What are biomarkers in the context of medical conditions?
Biomarkers are measurable substances or characteristics in the body that indicate a normal biological process, a disease process, or the body's response to a drug. They can be found in blood, urine, tissue, or other bodily fluids and are crucial for understanding health and disease. Data from ClinicalTrials.gov and NIH RePORTER show their broad application.
How are biomarkers used in clinical trials?
In clinical trials, biomarkers help researchers identify patients who might benefit most from a specific treatment, monitor a treatment's effectiveness, or predict disease progression. They can serve as early indicators of whether an investigational therapy is working, potentially speeding up drug development. This is a key area of research according to ClinicalTrials.gov.
What are the different types of biomarkers studied in trials?
Biomarkers can be categorized by their function: diagnostic (to detect disease), prognostic (to predict disease course), or predictive (to forecast treatment response). Examples include genetic mutations, protein levels, or imaging findings. Research on these types is ongoing across many conditions, as seen in NIH RePORTER.
Are there clinical trials specifically focused on discovering new biomarkers?
Yes, many clinical trials are dedicated to identifying and validating new biomarkers for various diseases. These studies often collect samples from patients to find novel indicators that could lead to earlier diagnosis, better risk assessment, or more targeted treatments in the future. ClinicalTrials.gov lists numerous such studies.
Who is eligible to participate in a clinical trial involving biomarkers?
Eligibility for biomarker-related clinical trials varies widely depending on the specific disease and the biomarker being studied. Criteria often include having a particular medical condition, certain genetic markers, or specific disease characteristics. Patients should review the detailed inclusion and exclusion criteria for each study on platforms like Find a Trial.
What are the phases of biomarker development in clinical trials?
Biomarker development often mirrors drug development phases. It begins with discovery and validation in preclinical studies, moves to early-phase clinical trials to test feasibility and safety, and then to later phases to confirm clinical utility and impact on patient outcomes. This rigorous process ensures reliability, as documented on ClinicalTrials.gov.
Do clinical trials involving biomarker testing cost money for participants?
Generally, participation in clinical trials, including those involving biomarker testing, does not incur costs for the patient. Study sponsors typically cover the expenses related to research-specific tests, procedures, and study drugs. However, standard medical care costs may still apply, as detailed in the informed consent process. This is common practice in trials listed on ClinicalTrials.gov.
What are some challenges in using biomarkers in clinical trials?
Challenges include ensuring biomarker reliability and reproducibility, standardizing testing methods across different labs, and interpreting their clinical significance. A biomarker's utility can also vary between patient populations or disease stages. Researchers are continually working to overcome these hurdles to integrate biomarkers effectively into patient care, as evidenced by NIH RePORTER.
How to find a biomarkers trial that fits you
- Describe your biomarkers situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all biomarkers trials →